MIAMI (CBSMiami) – Gilead, the shaper of remdesivir, the archetypal antiviral approved to dainty COVID-19, is announcing a information recall.
In a statement, the institution reports that 2 tons of its COVID-19 cause remdesivir whitethorn beryllium contaminated with solid particles.
READ MORE: Honda Issues Recall Over Hood Issue
While determination person been nary adverse events reported, successful theory, the particles could artifact humor vessels causing changeable and adjacent death.
READ MORE: Injunction Denied In Health Care Vaccination Fight
Gilead is notifying distributors and customers astir the problem.
The infused anti-viral attraction tin lone beryllium administered successful a controlled wellness attraction mounting similar a hospital.
MORE NEWS: Experts Believe Other States Could Switch To Electric Mowers Like California
Remdesivir is sold nether the marque sanction Veklury and was approved by the FDA for treating hospitalized COVID-19 patients 12 years and older.